{"eventGroups":[{"deathsNumAffected":0,"deathsNumAtRisk":25,"description":"Patients receive etoposide IV over 4 hours on day 0, filgrastim SC QD beginning day 1, and plerixafor SC 15-18 hours prior to apheresis. Patients unable to achieve target collection of \\>= 8 x 10\\^6 CD34+ cells/kg receive another dose of plerixafor followed by apheresis. Following the second apheresis, patients achieving =\\< 2 x 10\\^6 CD34+ cells/kg may continue filgrastim with plerixafor and continue collection according to the attending physician.\n\nplerixafor: Given SC\n\nfilgrastim: Given SC\n\netoposide: Given IV\n\nleukapheresis: Undergo apheresis","id":"EG000","otherNumAffected":0,"otherNumAtRisk":25,"seriousNumAffected":0,"seriousNumAtRisk":25,"title":"Treatment (Stem Cell Supermobilization)"}],"frequencyThreshold":"5","timeFrame":"Up to 1 year post-transplant"}